Submission + - Company submits for FDA approval single-dose drug to cure HIV/AIDS (google.com)
Aristos Mazer writes: The company American Gene Technologies believes it has a drug to cure HIV/AIDS. This is not one of those on-going maintenance drugs. This, they claim in 1000+ pages of FDA filing, is an out-right cure. The drug, AGT 103T, delivers a virus that performs cell and gene therapy.
In AGTâ(TM)s words: âoeGene therapy is a technique that allows doctors to treat a disorder by inserting genes into patientsâ(TM) cells to mitigate the underlying genetic drivers of disease. Human cells can be re-engineered to create highly-effective hunter/killers of invasive pathogens or cancer cells, or reprogramed to produce secretions that provide potent remedies to other disease conditions.â
If FDA approves, then AGT will have the green light to begin phase one clinical trials in January 2020.
In AGTâ(TM)s words: âoeGene therapy is a technique that allows doctors to treat a disorder by inserting genes into patientsâ(TM) cells to mitigate the underlying genetic drivers of disease. Human cells can be re-engineered to create highly-effective hunter/killers of invasive pathogens or cancer cells, or reprogramed to produce secretions that provide potent remedies to other disease conditions.â
If FDA approves, then AGT will have the green light to begin phase one clinical trials in January 2020.
